Fulgent Genetics (FLGT) Free Cash Flow (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Free Cash Flow for 11 consecutive years, with -$83.1 million as the latest value for Q4 2025.
- Quarterly Free Cash Flow fell 491.35% to -$83.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$124.2 million through Dec 2025, down 545.09% year-over-year, with the annual reading at -$124.2 million for FY2025, 545.09% down from the prior year.
- Free Cash Flow hit -$83.1 million in Q4 2025 for Fulgent Genetics, down from -$3.9 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $221.7 million in Q1 2021 to a low of -$83.1 million in Q4 2025.
- Historically, Free Cash Flow has averaged $30.5 million across 5 years, with a median of $6.6 million in 2022.
- Biggest five-year swings in Free Cash Flow: soared 38792.46% in 2021 and later tumbled 759.13% in 2024.
- Year by year, Free Cash Flow stood at $71.1 million in 2021, then tumbled by 59.94% to $28.5 million in 2022, then tumbled by 58.48% to $11.8 million in 2023, then soared by 79.59% to $21.2 million in 2024, then plummeted by 491.35% to -$83.1 million in 2025.
- Business Quant data shows Free Cash Flow for FLGT at -$83.1 million in Q4 2025, -$3.9 million in Q3 2025, and -$28.0 million in Q2 2025.